NAD and NAD precursors: help or hype? | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.

NAD and NAD precursors: help or hype? | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.Подробнее

How effective is NAD and its precursors for longevity?Подробнее

Are there “biomarkers” for aging? | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.Подробнее

175 - The biology of aging, rapamycin, and other interventions that target the aging processПодробнее

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.Подробнее

Potential Risks of NAD Supplements | Iñigo San-Millán, Ph.D. & Peter Attia, M.D.Подробнее

Biomarkers of aging and epigenetic clocks | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.Подробнее

The potential negative side effects rapamycin | Peter Attia, David Sabatini, & Matt KaeberleinПодробнее

Do NAD and NMN promote longevity?Подробнее

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)Подробнее

Does NAD+ Actually boost longevity? | Dr. Matt KaeberleinПодробнее

Antiaging diets: separating fact from fiction | Peter Attia and Matt KaeberleinПодробнее

The challenges of defining agingПодробнее

216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.Подробнее